Habib Bennaceur: New Perspectives on Patient-Centered Hemophilia Care at ISTH 2026
Habib Bennaceur, Senior Vice President of Rare Disease Unit at Novo Nordisk, shared a post on LinkedIn:
“Today I’m excited to be on the ground at ISTH in Paris – one of the most important moments in the haematology calendar, and a valuable opportunity to connect across the rare blood disorder space – with those living with these conditions, as well as colleagues, clinicians, nurses, and other community members.
What I value most about this congress is the energy around our shared sense of purpose.
For ISTH 2026, we’re presenting our own breadth of haemophilia data spanning ages and indications while also learning from the research and perspectives of others who are also exploring ways to deliver more and better for this community.
Despite significant progress, we know that people living with haemophilia still face daily trade-offs between protection from bleeds and the burden of treatment.
Alongside this is the mental load of managing that daily balance – something that is too often overlooked.
Challenging that reality is what continues to drive our passion and focus in this space.
At Novo Nordisk, we recognize that innovation in haemophilia is not only about preventing bleeds.
Our ambition is to give people genuine choice through options that fit within their real lives and reflect their individual needs.
For more than four decades, we have worked alongside this community; listening to their experiences, advancing the science, and deepening our understanding of what it means to live – and live well – with a rare bleeding disorder.
If you’re here in Paris, I encourage you to visit us at booth 907 and connect with our team.
I’m looking forward to the conversations ahead.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment